Moderna secures up to $54.3 million funding for bird flu vaccine from global coalition

Core Viewpoint - Moderna is set to receive up to $54.3 million in funding from a global coalition to aid in the late-stage development of its experimental bird flu vaccine [1] Group 1 - The funding will support the late-stage development of Moderna's bird flu vaccine [1] - The total amount of funding is $54.3 million [1]